Literature DB >> 22613664

Sequential bilateral central retinal artery occlusion as the primary manifestation of systemic lupus erythematosus.

Xuan Zou1, Yan Zhuang, Fang-tian Dong, Fan Zhang, You-xin Chen.   

Abstract

Bilateral central retinal artery occlusion (CRAO) has been rarely reported as the primary manifestation in patients with systemic lupus erythematosus (SLE). The severe retinal vaso-occlusive diseases usually cause devastating and permanent damage to visual function in spite of vigorous treatment. A 42-year-old Chinese woman presented with abrupt bilateral vision loss. The diagnosis of bilateral CRAO was suggested by the ocular presentation and fluorescein angiography. Laboratory studies showed positive results of antinuclear antibody, anti-Ro/SSA anti-La/SSB; decreased levels of C3, C4 complement and normal levels of antiphospholipides antibodies (APAs). Her visual acuity deteriorated despite systemic steroid and immunosuppressant treatment. Severe vaso-occlusive retinopathy may be an earlier manifestation of SLE without elevated level of APAs.

Entities:  

Mesh:

Year:  2012        PMID: 22613664

Source DB:  PubMed          Journal:  Chin Med J (Engl)        ISSN: 0366-6999            Impact factor:   2.628


  3 in total

1.  Bilateral simultaneous Central Retinal Artery Occlusion (CRAO) in a patient with Systemic Lupus Erythematosus (SLE).

Authors:  Kiran Chandran; Shailaja Bhat Shenoy; Chidanand Kulkarni; Namitha Rachel Mathew
Journal:  Am J Ophthalmol Case Rep       Date:  2020-07-20

2.  Severe ischemic retinopathy in a patient with systemic lupus erythematosus without antiphospholipid syndrome: A case report.

Authors:  El Asri Fouad; Momen Hanane; Belmalih Mounir; Zarrouk Rachid; Reda Karim; Oubaaz Abdelber
Journal:  Saudi J Ophthalmol       Date:  2014-09-22

3.  Severe Vaso-Occlusive Retinopathy in Systemic Lupus Erythematosus: A Case Series.

Authors:  Kshitiz Kumar; Shouvick Dan; Tushar K Sinha; Debashish Bhattacharya
Journal:  Cureus       Date:  2021-01-30
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.